Chemical name: 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile;
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid
FEMARA 5mg – PARA PHARMA
Femara 5 is a medication that is primarily used as a non-steroidal aromatase inhibitor. Its active half-life is approximately 2 days, which means that it stays active within the bloodstream for a short period. Femara 5 is classified as a non-steroidal aromatase inhibitor, meaning that it blocks the aromatase enzyme that converts androgens into estrogens in the body.
The recommended dosage for Femara 5 is between 2.5 – 5 mg per day. This dosage may vary depending on the individual’s age, sex, and medical history. Femara 5 is typically prescribed for breast cancer treatment, especially for postmenopausal women who have hormone receptor-positive breast cancer.
One of the key benefits of Femara 5 is that it does not cause acne, water retention, HBR, hepatotoxicity, or aromatization. These are all side effects that can occur with other medications of a similar nature, making Femara 5 less risky for long-term use.
The active substance in Femara 5 is Letrozole. This substance helps to prevent the conversion of androgens into estrogen, which is crucial in the treatment of hormone receptor-positive breast cancer.
Femara 5 is typically manufactured in 50 pills per bottle, with each pill containing 5 mg of Letrozole. It is manufactured by Para Pharma, a reputable and well-known manufacturer of pharmaceuticals.
In conclusion, Femara 5 is a medication that is primarily used for the treatment of hormone receptor-positive breast cancer in postmenopausal women. It has a short active half-life, does not cause side effects like acne or water retention, and is manufactured by Para Pharma in 50 pills per bottle. If you have been prescribed Femara 5, it is important to follow your doctor’s instructions regarding dosage and any potential side effects to ensure your health and safety.